Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
Clinical trial NCT04882007 · COMPLETED
Trial details
- NCT number
- NCT04882007
- Sponsor
- OSE Immunotherapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-02
- Primary completion
- 2024-04-30
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.